ERRβ: A potent inhibitor of Nrf2 transcriptional activity
Wei Zhou(Broad Institute), Dennis B. Lubahn(University of Missouri), Shih‐Ching Lo(Biogen (United States)), Mark Hannink(University of Missouri), Jing-Hua Liu(University of Missouri)
Cited by 53
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity.
|Proceedings of the National Academy of Sciences|1989|447
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome.
|Proceedings of the National Academy of Sciences|1988|209
Rapidly in Situ Forming Biodegradable Robust Hydrogels by Combining Stereocomplexation and Photopolymerization
|Journal of the American Chemical Society|2007|156